- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Japanese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Daiichi Sankyo Company
Market Cap: JP¥6.5t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥3,467.00
7D
4.9%
1Y
-22.4%
Chugai Pharmaceutical
Market Cap: JP¥13.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,522.00
7D
17.7%
1Y
32.6%